Narrow your search

Library

ULiège (3)

FARO (2)

KU Leuven (2)

LUCA School of Arts (2)

Odisee (2)

Thomas More Kempen (2)

Thomas More Mechelen (2)

UCLL (2)

ULB (2)

VIVES (2)

More...

Resource type

book (6)


Language

English (6)


Year
From To Submit

2022 (5)

2013 (1)

Listing 1 - 6 of 6
Sort by

Book
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : workshop summary
Authors: --- ---
ISBN: 0309265959 0309265967 0309265983 Year: 2013 Publisher: Washington, District of Columbia : National Academies Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB) a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin) face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks ; The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain ; What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]) ; The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration ; Identification of potential innovative solutions to the problem.


Book
Monitoring and Surveillance of Veterinary Antimicrobial Use and Antibiotic Resistance in Animals
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Antimicrobial resistance is a global One Health topic that affects us all, whether we are working in human or veterinary medicine. Although antibiotic use in farm animals is decreasing in many countries, other nations are still using these essential medical resources as growth promoters to boost economic gains. As veterinarians responsible for animal welfare, it is vital that we are permitted to treat sick animals effectively, but we must learn to be more prudent in our use of these drugs. It is essential that we, as responsible clinicians, policy makers, and researchers, develop methods of quantifying, monitoring, benchmarking, and reporting antibiotic use in both farm and companion animals, so that antimicrobial stewardship schemes can be implemented and their successes or failures analyzed. This Special Issue includes research on antibiotic use and resistance in a variety of animal species, covering cattle, sheep, pigs, poultry, and pets. The relationship between antimicrobial use and resistance in animals is investigated on a global scale, with authors from Austria, Australia, Brazil, Germany, Italy, India, the Netherlands, Peru, Portugal, Slovenia, and the United Kingdom.

Keywords

Medicine --- Escherichia coli --- antimicrobial resistance --- swine --- weaned piglet --- antibiotic growth promoters --- antibiotic --- antibiotic resistance --- livestock --- antibiotic use --- AMR --- MDR --- environment --- antimicrobial usage --- bovine --- India --- KAP survey --- veterinarians --- antimicrobial use --- antimicrobial resistance (AMR) --- Timor-Leste --- antimicrobial --- veterinary --- prudent use --- critically important antimicrobials --- growth promotion --- poultry --- sheep --- beef cattle --- normalised resistance interpretation --- antimicrobial susceptibility testing --- tetracyclines --- farms --- turkeys --- farm --- antimicrobial resistance genes --- biosecurity --- risk factor --- metagenomics --- qPCR --- isolates --- neonatal calf diarrhea --- survey --- antibiotics --- HPCIA --- urinary tract infection --- Flexicult Vet --- pathogen identification --- dogs --- cats --- veterinary microbiology --- bovine respiratory disease --- multidrug-resistance --- Pasteurella multocida --- Mannheimia haemolytica --- Truperella pyogenes --- dairy farm --- E. coli --- calves --- enteritis --- serotypes --- virulence --- multidrug-resistant --- extensively drug-resistant --- dairy --- ESBL --- MRSA --- dog --- canine parvovirus --- Carnivore protoparvovirus 1 --- multidrug resistance --- One Health --- Enterobacteriaceae --- public awareness --- farmworkers --- chicken --- growth promoters --- Staphylococcus hyicus --- PFGE --- exudative epidermitis --- pigs --- monitoring --- carbapenems --- CPE --- meat-producing animal --- companion animal --- travelers --- feed --- risk assessment --- introduction risk --- stochastic risk model --- coagulase-negative Staphylococcus --- CoNS --- quails --- broilers


Book
Monitoring and Surveillance of Veterinary Antimicrobial Use and Antibiotic Resistance in Animals
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Antimicrobial resistance is a global One Health topic that affects us all, whether we are working in human or veterinary medicine. Although antibiotic use in farm animals is decreasing in many countries, other nations are still using these essential medical resources as growth promoters to boost economic gains. As veterinarians responsible for animal welfare, it is vital that we are permitted to treat sick animals effectively, but we must learn to be more prudent in our use of these drugs. It is essential that we, as responsible clinicians, policy makers, and researchers, develop methods of quantifying, monitoring, benchmarking, and reporting antibiotic use in both farm and companion animals, so that antimicrobial stewardship schemes can be implemented and their successes or failures analyzed. This Special Issue includes research on antibiotic use and resistance in a variety of animal species, covering cattle, sheep, pigs, poultry, and pets. The relationship between antimicrobial use and resistance in animals is investigated on a global scale, with authors from Austria, Australia, Brazil, Germany, Italy, India, the Netherlands, Peru, Portugal, Slovenia, and the United Kingdom.

Keywords

Escherichia coli --- antimicrobial resistance --- swine --- weaned piglet --- antibiotic growth promoters --- antibiotic --- antibiotic resistance --- livestock --- antibiotic use --- AMR --- MDR --- environment --- antimicrobial usage --- bovine --- India --- KAP survey --- veterinarians --- antimicrobial use --- antimicrobial resistance (AMR) --- Timor-Leste --- antimicrobial --- veterinary --- prudent use --- critically important antimicrobials --- growth promotion --- poultry --- sheep --- beef cattle --- normalised resistance interpretation --- antimicrobial susceptibility testing --- tetracyclines --- farms --- turkeys --- farm --- antimicrobial resistance genes --- biosecurity --- risk factor --- metagenomics --- qPCR --- isolates --- neonatal calf diarrhea --- survey --- antibiotics --- HPCIA --- urinary tract infection --- Flexicult Vet --- pathogen identification --- dogs --- cats --- veterinary microbiology --- bovine respiratory disease --- multidrug-resistance --- Pasteurella multocida --- Mannheimia haemolytica --- Truperella pyogenes --- dairy farm --- E. coli --- calves --- enteritis --- serotypes --- virulence --- multidrug-resistant --- extensively drug-resistant --- dairy --- ESBL --- MRSA --- dog --- canine parvovirus --- Carnivore protoparvovirus 1 --- multidrug resistance --- One Health --- Enterobacteriaceae --- public awareness --- farmworkers --- chicken --- growth promoters --- Staphylococcus hyicus --- PFGE --- exudative epidermitis --- pigs --- monitoring --- carbapenems --- CPE --- meat-producing animal --- companion animal --- travelers --- feed --- risk assessment --- introduction risk --- stochastic risk model --- coagulase-negative Staphylococcus --- CoNS --- quails --- broilers


Book
Carbapenemase-Producing Enterobacterales
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Carbapenem-resistant Enterobacterales (CRE) are a common cause of infections in both community and healthcare settings and have become an increasing threat to public health worldwide. The focus of this Special Issue includes aspects concerning plasmid-mediated antimicrobial resistance along with other carbapenem resistance mechanisms. Understanding the prevalence and routes of transmission of CRE is important in developing specific interventions for healthcare facilities, as well as the general impact of CRE circulation on the environment. Attention has also been focused on carbapenemase testing in order to provide advanced phenotypic and molecular assays for the identification of CRE, as a valid tool for active global surveillance, and from this perspective, the study of resistance mechanisms can provide significant support for the development of new and appropriate antimicrobial molecules. For all of these reasons, the phenomenon of carbapenem resistance deserves more attention, for the sake of public health.

Keywords

Research & information: general --- Biology, life sciences --- Microbiology (non-medical) --- carbapenem resistance --- carbapenemase --- whole genome sequencing --- long reads, plasmid --- Klebsiella pneumoniae --- extensively drug-resistant --- molecular typing --- carbapenemases --- Enterobacteriales --- human --- animal --- food --- environment --- carbapenemase-producing Enterobacterales --- KPC --- carbapenem --- multidrug resistance --- nosocomial --- Enterobacteriaceae --- ESBL --- resistance genes --- cattle --- blaOXA-48 --- ERIC-PCR --- plasmid profile analysis --- biofilm formation --- PCR-based replicon typing --- antibiotic-resistance --- sequence types --- multilocus sequence typing --- plasmids --- antimicrobial resistance --- carbapenem inactivation method --- carbapenem-resistant Enterobacterales --- real-time multiplex PCR --- whole-genome sequencing --- carbapenem-resistance --- Qatar --- CRE --- OXA-48 --- carbapenems resistance --- Gram-negative bacteria --- infection --- colonization --- COVID-19 --- K. pneumoniae --- porins --- ceftazidime/avibactam --- ESKAPE --- healthcare-associated infections --- antimicrobial peptides --- Temporin L --- Klebsiella michiganensis --- Citrobacter farmeri --- KPC-2 --- plasmid --- transposon --- carbapenem-resistant Enterobacteriaceae (CRE) --- outbreak --- infection control --- pulsed-field gel electrophoresis (PFGE) --- multilocus sequence typing (MLST) --- IMP-6 --- porin --- efflux pump --- nosocomial infections --- NDM-1 --- Fourier transform infrared spectroscopy --- Eazyplex® SuperBug CRE assay --- extended-spectrum beta-lactamases --- gram-negative rods --- LAMP method --- NDM --- VIM --- molecular epidemiology --- PFGE --- Carbapenemase producing Enterobacterales --- IncX-3 --- one health --- water --- colistin susceptibility testing --- broth microdilution --- colistin broth disc elution --- Vitek 2 compact --- rapid polymyxin NP test --- Etest --- ChromID colistin R agar --- micronaut MIC-strip colistin --- population analysis profiling --- Enterobacterales --- neonates --- plasmid-typing --- sequence type --- wastewater --- virulence


Book
Carbapenemase-Producing Enterobacterales
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Carbapenem-resistant Enterobacterales (CRE) are a common cause of infections in both community and healthcare settings and have become an increasing threat to public health worldwide. The focus of this Special Issue includes aspects concerning plasmid-mediated antimicrobial resistance along with other carbapenem resistance mechanisms. Understanding the prevalence and routes of transmission of CRE is important in developing specific interventions for healthcare facilities, as well as the general impact of CRE circulation on the environment. Attention has also been focused on carbapenemase testing in order to provide advanced phenotypic and molecular assays for the identification of CRE, as a valid tool for active global surveillance, and from this perspective, the study of resistance mechanisms can provide significant support for the development of new and appropriate antimicrobial molecules. For all of these reasons, the phenomenon of carbapenem resistance deserves more attention, for the sake of public health.

Keywords

Research & information: general --- Biology, life sciences --- Microbiology (non-medical) --- carbapenem resistance --- carbapenemase --- whole genome sequencing --- long reads, plasmid --- Klebsiella pneumoniae --- extensively drug-resistant --- molecular typing --- carbapenemases --- Enterobacteriales --- human --- animal --- food --- environment --- carbapenemase-producing Enterobacterales --- KPC --- carbapenem --- multidrug resistance --- nosocomial --- Enterobacteriaceae --- ESBL --- resistance genes --- cattle --- blaOXA-48 --- ERIC-PCR --- plasmid profile analysis --- biofilm formation --- PCR-based replicon typing --- antibiotic-resistance --- sequence types --- multilocus sequence typing --- plasmids --- antimicrobial resistance --- carbapenem inactivation method --- carbapenem-resistant Enterobacterales --- real-time multiplex PCR --- whole-genome sequencing --- carbapenem-resistance --- Qatar --- CRE --- OXA-48 --- carbapenems resistance --- Gram-negative bacteria --- infection --- colonization --- COVID-19 --- K. pneumoniae --- porins --- ceftazidime/avibactam --- ESKAPE --- healthcare-associated infections --- antimicrobial peptides --- Temporin L --- Klebsiella michiganensis --- Citrobacter farmeri --- KPC-2 --- plasmid --- transposon --- carbapenem-resistant Enterobacteriaceae (CRE) --- outbreak --- infection control --- pulsed-field gel electrophoresis (PFGE) --- multilocus sequence typing (MLST) --- IMP-6 --- porin --- efflux pump --- nosocomial infections --- NDM-1 --- Fourier transform infrared spectroscopy --- Eazyplex® SuperBug CRE assay --- extended-spectrum beta-lactamases --- gram-negative rods --- LAMP method --- NDM --- VIM --- molecular epidemiology --- PFGE --- Carbapenemase producing Enterobacterales --- IncX-3 --- one health --- water --- colistin susceptibility testing --- broth microdilution --- colistin broth disc elution --- Vitek 2 compact --- rapid polymyxin NP test --- Etest --- ChromID colistin R agar --- micronaut MIC-strip colistin --- population analysis profiling --- Enterobacterales --- neonates --- plasmid-typing --- sequence type --- wastewater --- virulence


Book
Carbapenemase-Producing Enterobacterales
Author:
Year: 2022 Publisher: Basel MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Carbapenem-resistant Enterobacterales (CRE) are a common cause of infections in both community and healthcare settings and have become an increasing threat to public health worldwide. The focus of this Special Issue includes aspects concerning plasmid-mediated antimicrobial resistance along with other carbapenem resistance mechanisms. Understanding the prevalence and routes of transmission of CRE is important in developing specific interventions for healthcare facilities, as well as the general impact of CRE circulation on the environment. Attention has also been focused on carbapenemase testing in order to provide advanced phenotypic and molecular assays for the identification of CRE, as a valid tool for active global surveillance, and from this perspective, the study of resistance mechanisms can provide significant support for the development of new and appropriate antimicrobial molecules. For all of these reasons, the phenomenon of carbapenem resistance deserves more attention, for the sake of public health.

Keywords

carbapenem resistance --- carbapenemase --- whole genome sequencing --- long reads, plasmid --- Klebsiella pneumoniae --- extensively drug-resistant --- molecular typing --- carbapenemases --- Enterobacteriales --- human --- animal --- food --- environment --- carbapenemase-producing Enterobacterales --- KPC --- carbapenem --- multidrug resistance --- nosocomial --- Enterobacteriaceae --- ESBL --- resistance genes --- cattle --- blaOXA-48 --- ERIC-PCR --- plasmid profile analysis --- biofilm formation --- PCR-based replicon typing --- antibiotic-resistance --- sequence types --- multilocus sequence typing --- plasmids --- antimicrobial resistance --- carbapenem inactivation method --- carbapenem-resistant Enterobacterales --- real-time multiplex PCR --- whole-genome sequencing --- carbapenem-resistance --- Qatar --- CRE --- OXA-48 --- carbapenems resistance --- Gram-negative bacteria --- infection --- colonization --- COVID-19 --- K. pneumoniae --- porins --- ceftazidime/avibactam --- ESKAPE --- healthcare-associated infections --- antimicrobial peptides --- Temporin L --- Klebsiella michiganensis --- Citrobacter farmeri --- KPC-2 --- plasmid --- transposon --- carbapenem-resistant Enterobacteriaceae (CRE) --- outbreak --- infection control --- pulsed-field gel electrophoresis (PFGE) --- multilocus sequence typing (MLST) --- IMP-6 --- porin --- efflux pump --- nosocomial infections --- NDM-1 --- Fourier transform infrared spectroscopy --- Eazyplex® SuperBug CRE assay --- extended-spectrum beta-lactamases --- gram-negative rods --- LAMP method --- NDM --- VIM --- molecular epidemiology --- PFGE --- Carbapenemase producing Enterobacterales --- IncX-3 --- one health --- water --- colistin susceptibility testing --- broth microdilution --- colistin broth disc elution --- Vitek 2 compact --- rapid polymyxin NP test --- Etest --- ChromID colistin R agar --- micronaut MIC-strip colistin --- population analysis profiling --- Enterobacterales --- neonates --- plasmid-typing --- sequence type --- wastewater --- virulence

Listing 1 - 6 of 6
Sort by